Seminars and thesis defences
ldri | Bruxelles Woluwe
-
DFAR Seminar - Lisa FLASSE and Mert Can YILDIRIM18 May18 May...Lisa FLASSE - IREC/LTAP
New mechanistic insights into the adverse outcomes of low-toxicity persistent particlesMert Can YILDIRIM - TFAR/FACM
Asymmetric Membrane Properties as Determinants of Antibiotic Permeation, Activity, and Bacterial AdaptationRead more
DFAR Seminar - Lisa FLASSE and Mert Can YILDIRIM18 May18 May...Lisa FLASSE - IREC/LTAP
New mechanistic insights into the adverse outcomes of low-toxicity persistent particlesMert Can YILDIRIM - TFAR/FACM
Asymmetric Membrane Properties as Determinants of Antibiotic Permeation, Activity, and Bacterial Adaptation -
DFAR Seminar - Paul PARRENS and Elsa TEMPERMAN04 May04 May...Paul PARRENS – ADDB
Peptide derivatives against intracellular S. aureus persisters: selecting lead compounds for future formulationElsa TEMPERMAN - BPBL
The effect of endocannabinoid-derived prostaglandins and of ABHD6 inhibition in lung inflammationRead more
DFAR Seminar - Paul PARRENS and Elsa TEMPERMAN04 May04 May...Paul PARRENS – ADDB
Peptide derivatives against intracellular S. aureus persisters: selecting lead compounds for future formulationElsa TEMPERMAN - BPBL
The effect of endocannabinoid-derived prostaglandins and of ABHD6 inhibition in lung inflammation -
LDRI Seminar - Dr Bradley WARD27 Apr27 Apr...Dr Bradley WARD - TFAR PMGK - Postdoctoral Researcher in Bioinformatics and Multi-Omics Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics
The use and development of exploratory multi-omic analysis for complex disease: A COVID-19 Proof-of-concept
Related publications:
• Ward B, Yombi JC, Balligand JL, Cani PD, Collet JF, de Greef J, Dewulf JP, Gatto L, Haufroid V, Jodogne S, Kabamba B, Pyr Dit Ruys S, Vertommen D, Elens L, Belkhir L. HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach. Viruses. 2022 Jun 23;14(7):1373. doi : 10.3390/v14071373.
• Bradley Ward, Sébastien Pyr dit Ruys, Jean-Luc Balligand, Leïla Belkhir, Patrice D. Cani, Jean-François Collet, Julien De Greef, Joseph P. Dewulf, Laurent Gatto, Vincent Haufroid, Sébastien Jodogne, Benoît Kabamba, Maxime Lingurski, Jean Cyr Yombi, Didier Vertommen, and Laure Elens. Deep Plasma Proteomics with Data-Independent Acquisition: Clinical Study Protocol Optimization with a COVID-19 Cohort. Journal of Proteome Research. 2024 23 (9), 3806-3822. doi: 10.1021/acs.jproteome.4c00104.
• Bradley Ward, Laure B. Bindels, Jean-Luc Balligand, Bertrand Bearzatto, Guido Bommer, Patrice D. Cani, Julien De Greef, Joseph P. Dewulf, Laurent Gatto12, Vincent Haufroid, Sébastien Jodogne, Benoît Kabamba, Sébastien Pyr dit Ruys, Didier Vertommen, Jean Cyr Yombi, Leïla Belkhir, Laure Elens. Association of nasopharyngeal Dolosigranulum pigrum and Corynebacterium species with post-acute sequelae of SARS-CoV-2 in a longitudinal cohort. Microbiology Spectrum. (in press).Info: laure.elens@uclouvain.be
Read more
LDRI Seminar - Dr Bradley WARD27 Apr27 Apr...Dr Bradley WARD - TFAR PMGK - Postdoctoral Researcher in Bioinformatics and Multi-Omics Integrated PharmacoMetrics, PharmacoGenomics and PharmacoKinetics
The use and development of exploratory multi-omic analysis for complex disease: A COVID-19 Proof-of-concept
Related publications:
• Ward B, Yombi JC, Balligand JL, Cani PD, Collet JF, de Greef J, Dewulf JP, Gatto L, Haufroid V, Jodogne S, Kabamba B, Pyr Dit Ruys S, Vertommen D, Elens L, Belkhir L. HYGIEIA: HYpothesizing the Genesis of Infectious Diseases and Epidemics through an Integrated Systems Biology Approach. Viruses. 2022 Jun 23;14(7):1373. doi : 10.3390/v14071373.
• Bradley Ward, Sébastien Pyr dit Ruys, Jean-Luc Balligand, Leïla Belkhir, Patrice D. Cani, Jean-François Collet, Julien De Greef, Joseph P. Dewulf, Laurent Gatto, Vincent Haufroid, Sébastien Jodogne, Benoît Kabamba, Maxime Lingurski, Jean Cyr Yombi, Didier Vertommen, and Laure Elens. Deep Plasma Proteomics with Data-Independent Acquisition: Clinical Study Protocol Optimization with a COVID-19 Cohort. Journal of Proteome Research. 2024 23 (9), 3806-3822. doi: 10.1021/acs.jproteome.4c00104.
• Bradley Ward, Laure B. Bindels, Jean-Luc Balligand, Bertrand Bearzatto, Guido Bommer, Patrice D. Cani, Julien De Greef, Joseph P. Dewulf, Laurent Gatto12, Vincent Haufroid, Sébastien Jodogne, Benoît Kabamba, Sébastien Pyr dit Ruys, Didier Vertommen, Jean Cyr Yombi, Leïla Belkhir, Laure Elens. Association of nasopharyngeal Dolosigranulum pigrum and Corynebacterium species with post-acute sequelae of SARS-CoV-2 in a longitudinal cohort. Microbiology Spectrum. (in press).Info: laure.elens@uclouvain.be
-
Thesis public defense - Chi-Hsien LEE22 Apr22 Apr...
Wednesday April 22, 2026 – 4pm – Auditoire 51G
Chi-Hsien LEE – MNUT
Discovery of a novel myo-inositol to butyrate fermentation pathway and taxonomic expansion of the genus Dysosmobacter in the human gut
Promotor: Prof. Patrice Cani
Related publications:
• Lee C-H, Bui TPN, Petitfils C, Jian C, Wong GC, Puel A, Le Roy T, Bellais S, Ben Abdallah B, Nehlich M, Leicht T, Jia M, Hoyles L, Federici M, Fernández-Real JM, Burcelin R, Dumas M-E, Delzenne NM, Clavel T, Boeren S, Troise AD, Scaloni A, Muccioli GG, de Vos WM, Van Hul M, Cani PD. Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health. Gut. 2026; doi:10.1136/gutjnl-2025-336617.
• Lee C-H, Petitfils C, Bui TPN, Van Der Smissen P, Delzenne NM, Tyteca D, de Vos WM, Van Hul M, Cani PD. Dysosmobacter phytatis sp. nov., isolated from human feces, with Oscillibacter acetigenes as a later heterotypic synonym of Dysosmobacter welbionis and Pusillibacter faecalis as a later heterotypic synonym of Dysosmobacter hominis. Submitted to IJSEM in 2026.Info: patrice.cani@uclouvain.be
Read moreThesis public defense - Chi-Hsien LEE22 Apr22 Apr...Wednesday April 22, 2026 – 4pm – Auditoire 51G
Chi-Hsien LEE – MNUT
Discovery of a novel myo-inositol to butyrate fermentation pathway and taxonomic expansion of the genus Dysosmobacter in the human gut
Promotor: Prof. Patrice Cani
Related publications:
• Lee C-H, Bui TPN, Petitfils C, Jian C, Wong GC, Puel A, Le Roy T, Bellais S, Ben Abdallah B, Nehlich M, Leicht T, Jia M, Hoyles L, Federici M, Fernández-Real JM, Burcelin R, Dumas M-E, Delzenne NM, Clavel T, Boeren S, Troise AD, Scaloni A, Muccioli GG, de Vos WM, Van Hul M, Cani PD. Novel myo-inositol to butyrate fermentation pathway in the prevalent human gut species Dysosmobacter welbionis, a bacterium associated with improved metabolic and liver health. Gut. 2026; doi:10.1136/gutjnl-2025-336617.
• Lee C-H, Petitfils C, Bui TPN, Van Der Smissen P, Delzenne NM, Tyteca D, de Vos WM, Van Hul M, Cani PD. Dysosmobacter phytatis sp. nov., isolated from human feces, with Oscillibacter acetigenes as a later heterotypic synonym of Dysosmobacter welbionis and Pusillibacter faecalis as a later heterotypic synonym of Dysosmobacter hominis. Submitted to IJSEM in 2026.Info: patrice.cani@uclouvain.be
-
DFAR Seminar - Lorine LEMAIRE and Marie-Sophie MARTOU20 Apr20 Apr...Lorine LEMAIRE – ADDB and MITH (VUB)
Design of an anti-elastase nanomedicine to prevent the evolution of emphysema in chronic obstructive pulmonary diseaseMarie-Sophie MARTOU – CMFA and IREC/FATH
Creating anti-angiogenic miniproteins targeting protein-protein interactions as a new strategy in anticancer therapyRead more
DFAR Seminar - Lorine LEMAIRE and Marie-Sophie MARTOU20 Apr20 Apr...Lorine LEMAIRE – ADDB and MITH (VUB)
Design of an anti-elastase nanomedicine to prevent the evolution of emphysema in chronic obstructive pulmonary diseaseMarie-Sophie MARTOU – CMFA and IREC/FATH
Creating anti-angiogenic miniproteins targeting protein-protein interactions as a new strategy in anticancer therapy -
LDRI Seminar - Prof. Twan LAMMERS13 Apr13 Apr...Prof. Twan LAMMERS - Department of Nanomedicine and Theranostics - Institute for Experimental Molecular Imaging - RWTH Aachen University Clinic – Aachen, Germany
Strategies to Promote Cancer Nanomedicine Performance and Clinical Translation
Related publications:
• Dasgupta A, Sun T, Palomba R, Rama E, Zhang Y, Power C, Liu M, Sarode A, Weiler M, Motta A, Porte C, Magnuska Z, Elshafei A, Barmin R, Graham A, McClelland A, Rommel D, Stickeler E, Kiessling F, Pallares R, De Laporte L, Decuzzi P, McDannold N, Mitragotri S, Lammers T. Non-spherical ultrasound microbubbles. PNAS 2023, 120, e2218847120
• Dasgupta A, Sun T, Rama E, Motta A, Zhang Y, Power C, Moeckel D, Moosavifar M, Barmin R, Porte C, Buhl E, Bastard C, Pallares R, Kiessling F, McDannold N, Mitragotri S, Lammers T. Transferrin receptor-targeted nonspherical microbubbles for blood-brain barrier sonopermeation. Adv Mater 2023, 35, e2308150
• Dasgupta A, Sofias A, Kiessling F, Lammers T. Nanoparticle delivery to tumors: From EPR and ATR mechanisms to clinical impact. Nat Rev Bioeng 2024, 2, 714-716
• Pallares R, Consolino L, Wang A, De Lorenzi F, Kiessling F, Schroeder A, Lammers T. Targeting metastasis with nanomedicine. Nat Rev Bioeng 2026 (in press)Info: ana.beloqui@uclouvain.be
Read more
LDRI Seminar - Prof. Twan LAMMERS13 Apr13 Apr...Prof. Twan LAMMERS - Department of Nanomedicine and Theranostics - Institute for Experimental Molecular Imaging - RWTH Aachen University Clinic – Aachen, Germany
Strategies to Promote Cancer Nanomedicine Performance and Clinical Translation
Related publications:
• Dasgupta A, Sun T, Palomba R, Rama E, Zhang Y, Power C, Liu M, Sarode A, Weiler M, Motta A, Porte C, Magnuska Z, Elshafei A, Barmin R, Graham A, McClelland A, Rommel D, Stickeler E, Kiessling F, Pallares R, De Laporte L, Decuzzi P, McDannold N, Mitragotri S, Lammers T. Non-spherical ultrasound microbubbles. PNAS 2023, 120, e2218847120
• Dasgupta A, Sun T, Rama E, Motta A, Zhang Y, Power C, Moeckel D, Moosavifar M, Barmin R, Porte C, Buhl E, Bastard C, Pallares R, Kiessling F, McDannold N, Mitragotri S, Lammers T. Transferrin receptor-targeted nonspherical microbubbles for blood-brain barrier sonopermeation. Adv Mater 2023, 35, e2308150
• Dasgupta A, Sofias A, Kiessling F, Lammers T. Nanoparticle delivery to tumors: From EPR and ATR mechanisms to clinical impact. Nat Rev Bioeng 2024, 2, 714-716
• Pallares R, Consolino L, Wang A, De Lorenzi F, Kiessling F, Schroeder A, Lammers T. Targeting metastasis with nanomedicine. Nat Rev Bioeng 2026 (in press)Info: ana.beloqui@uclouvain.be
-
Thesis public defence - Darius MAZHARI DOROOEE10 Apr10 Apr...Darius MAZHARI DOROOEE – CMFA
Structural and mechanistic investigation of the acyl-CoA synthetase long-chain family member 4 (ACSL4) inhibition in the context of ferroptosis-related diseases and cancer
Promotor: Prof. Raphaël Frédérick
Co-promotor: Dr Jamal El Bakali (Université de Lille)Related publications:
• Mazhari Dorooee Darius, Ravez Séverine, Vertommen Didier, Renault Nicolas, Papadopoulos Nicolas, Marteau Romain, Charnelle Emeline, Porte Karine, Gobert Alexandre, Hennuyer Nathalie, Herinckx Gaetan, Pautric Maëla, Jonneaux Aurélie, Devedjian Jean Christophe, Devos David, Staels Bart, Melnyk Patricia, Constantinescu Stefan N, Frédérick Raphaël°, El Bakali Jamal°. LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode (2025) Angewandte Chemie - International Edition, e202500518.
• Marteau Romain*, Ravez Séverine*, Mazhari Dorooee Darius, Bouchaoui Hind, Porte Karine, Devedjian Jean Christophe, Melnyk Patricia, Devos David, Frédérick Raphaël°, El Bakali Jamal°. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis (2022) Biochemical Pharmacology, 204: 115239
• Charnelle Emeline*, Gobert Alexandre*, Marteau Romain, Pautric Maëla, Renault Nicolas, Jonneaux Aurélie, Mazhari Dorooee Darius, Laversin Amélie, Devedjian Jean-christophe, Melnyk Patricia, Yous Saïd, Devos David, Frédérick Raphaël, Ravez Séverine°, El Bakali Jamal°. Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties (2025) Journal of Medicinal Chemistry.Read more
Thesis public defence - Darius MAZHARI DOROOEE10 Apr10 Apr...Darius MAZHARI DOROOEE – CMFA
Structural and mechanistic investigation of the acyl-CoA synthetase long-chain family member 4 (ACSL4) inhibition in the context of ferroptosis-related diseases and cancer
Promotor: Prof. Raphaël Frédérick
Co-promotor: Dr Jamal El Bakali (Université de Lille)Related publications:
• Mazhari Dorooee Darius, Ravez Séverine, Vertommen Didier, Renault Nicolas, Papadopoulos Nicolas, Marteau Romain, Charnelle Emeline, Porte Karine, Gobert Alexandre, Hennuyer Nathalie, Herinckx Gaetan, Pautric Maëla, Jonneaux Aurélie, Devedjian Jean Christophe, Devos David, Staels Bart, Melnyk Patricia, Constantinescu Stefan N, Frédérick Raphaël°, El Bakali Jamal°. LIBX-A401: A Novel Selective Inhibitor of Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) and Its Binding Mode (2025) Angewandte Chemie - International Edition, e202500518.
• Marteau Romain*, Ravez Séverine*, Mazhari Dorooee Darius, Bouchaoui Hind, Porte Karine, Devedjian Jean Christophe, Melnyk Patricia, Devos David, Frédérick Raphaël°, El Bakali Jamal°. Repositioning of FDA-Approved antifungal agents to interrogate Acyl-CoA synthetase long chain family member 4 (ACSL4) in ferroptosis (2022) Biochemical Pharmacology, 204: 115239
• Charnelle Emeline*, Gobert Alexandre*, Marteau Romain, Pautric Maëla, Renault Nicolas, Jonneaux Aurélie, Mazhari Dorooee Darius, Laversin Amélie, Devedjian Jean-christophe, Melnyk Patricia, Yous Saïd, Devos David, Frédérick Raphaël, Ravez Séverine°, El Bakali Jamal°. Discovery of Potent Acyl-CoA Synthetase Long-Chain Family Member 4 (ACSL4) Inhibitors with Antiferroptotic Properties (2025) Journal of Medicinal Chemistry. -
LDRI Seminar - Dr Evelyne VAN den BROUCKE07 Apr07 Apr...Dr Evelyne VAN den BROUCKE - Pharmacy Department, University Hospitals Leuven - Advancing Pharmacist-Led Services for Optimised Pharmacotherapy
Expanding the Check of Medication Appropriateness (CMA), Developing the Check of Compounding Appropriateness (CCA) & Establishing a Centre for Medicines Information (CMI)
Related publications:
• Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients. Valerie Caubergs, Evelyne Van den Broucke, Beatrijs Mertens, Matthias Gijsen, Willy E. Peetermans, Eric Van Wijngaerden, Stefanie Desmet, Katrien Lagrou, Peter Declercq, Charlotte Quintens & Isabel Spriet. Infection, Volume 52, pages 2297–2314, (2024). doi: 10.1007/s15010-024-02279-w
• Antimicrobial stewardship strategies for implementing the 2019 EUCAST “I” definition. Evelyne Van den Broucke, Charlotte Quintens, Willy E. Peetermans, Eric Van Wijngaerden, Otto Van de gaer, Stefanie Desmet & Isabel Spriet. BMC Infectious Diseases, Volume 26, article number 24, (2026). doi: 10.1186/s12879-025-11943-xRead more
LDRI Seminar - Dr Evelyne VAN den BROUCKE07 Apr07 Apr...Dr Evelyne VAN den BROUCKE - Pharmacy Department, University Hospitals Leuven - Advancing Pharmacist-Led Services for Optimised Pharmacotherapy
Expanding the Check of Medication Appropriateness (CMA), Developing the Check of Compounding Appropriateness (CCA) & Establishing a Centre for Medicines Information (CMI)
Related publications:
• Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients. Valerie Caubergs, Evelyne Van den Broucke, Beatrijs Mertens, Matthias Gijsen, Willy E. Peetermans, Eric Van Wijngaerden, Stefanie Desmet, Katrien Lagrou, Peter Declercq, Charlotte Quintens & Isabel Spriet. Infection, Volume 52, pages 2297–2314, (2024). doi: 10.1007/s15010-024-02279-w
• Antimicrobial stewardship strategies for implementing the 2019 EUCAST “I” definition. Evelyne Van den Broucke, Charlotte Quintens, Willy E. Peetermans, Eric Van Wijngaerden, Otto Van de gaer, Stefanie Desmet & Isabel Spriet. BMC Infectious Diseases, Volume 26, article number 24, (2026). doi: 10.1186/s12879-025-11943-x -
DFAR Seminar - Eloïse VIERA OLIVERA and Daria KOVRYZHENKO30 Mar30 Mar...Eloïse VIERA OLIVERA – MNUT
Interest of volatilome analysis in the eludication of gut microbiota – host interactions in nutrition and health
Prom: Prof. Nathalie DELZENNEDaria KOVRYZHENKO - TFAR FACM
Membrane properties upon aggressiveness and invasiveness of glioblastoma cells in relation to mechanosensation
Prom: Prof. Joseph LorentRead more
DFAR Seminar - Eloïse VIERA OLIVERA and Daria KOVRYZHENKO30 Mar30 Mar...Eloïse VIERA OLIVERA – MNUT
Interest of volatilome analysis in the eludication of gut microbiota – host interactions in nutrition and health
Prom: Prof. Nathalie DELZENNEDaria KOVRYZHENKO - TFAR FACM
Membrane properties upon aggressiveness and invasiveness of glioblastoma cells in relation to mechanosensation
Prom: Prof. Joseph Lorent